Related Experiment Videos
Deep Venous Thrombosis and Pulmonary Embolism
Steven R. Deitcher1, Teresa L. Carman
1Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk S-60, Cleveland, OH 44195, USA. deitchs@ccf.org
Current Treatment Options in Cardiovascular Medicine
|May 11, 2002
Summary
Prompt diagnosis and treatment of venous thromboembolic disease (VTD), including deep venous thrombosis (DVT) and pulmonary embolism (PE), are crucial. Early anticoagulation with low molecular weight heparin (LMWH) and oral warfarin, alongside compression garments, improves outcomes.
Area of Science:
- Vascular Medicine
- Hematology
- Cardiology
Background:
- Venous thromboembolic disease (VTD), encompassing deep venous thrombosis (DVT) and pulmonary embolism (PE), is a significant cause of morbidity and mortality.
- Inadequate thromboprophylaxis in surgical and medically ill patients leads to increased healthcare costs and adverse patient outcomes.
- Delayed or missed diagnosis of DVT and PE results in severe complications, including postthrombotic syndrome, pulmonary hypertension, and recurrent thrombosis.
Purpose of the Study:
- To outline evidence-based strategies for the diagnosis and management of acute venous thromboembolic disease.
- To emphasize the importance of timely anticoagulation to prevent VTE propagation, embolization, and recurrence.
- To discuss long-term management, including duration of therapy and prevention of postthrombotic syndrome.
Main Methods:
- Clinical suspicion combined with evidence-based diagnostic tests for acute thrombosis identification.
- Immediate initiation of parenteral anticoagulation (unfractionated heparin or low molecular weight heparin [LMWH]).
- Conversion to oral anticoagulation (warfarin) with a target INR of 2.0-3.0, ensuring overlap with parenteral therapy.
Main Results:
- Weight-based LMWH is favored for DVT management, allowing for outpatient treatment in most cases.
- Patients with PE are admitted for a minimum of 2 days for observation.
- A minimum of 3-6 months of anticoagulation is recommended for idiopathic DVT and PE; shorter courses for situational DVT.
Conclusions:
- Prompt diagnosis and initiation of anticoagulation are essential for minimizing morbidity and mortality associated with VTE.
- Long-term anticoagulation is indicated for persistent hypercoagulable states, while thrombolytic therapy is reserved for specific severe cases.
- Prevention of postthrombotic syndrome and appropriate cancer screening are vital components of VTE management.